Pharmaceutical Murder With Remdesivir

Published on April 14, 2022

In a warning published early last year, the FDA stated that remdesivir could cause liver injury, allergic reactions, sudden changes in blood pressure and heart rate, low blood oxygen level, fever, shortness of breath, wheezing, swelling around the lips and eyes, nausea, sweating and shivering. Why these reactions?

During the pandemic, hospitals became hell holes killing more COVID patients than they helped with deadly treatments like remdesivir, which, believe it or not, seems to be a synthetic form of snake venom. Thus many have thought that it wasn’t the virus killing people as much as the treatment, specifically Remdesivir poisoning.

Is it absurd that a pharmaceutical company would use snake venom proteins in a drug? Researchers in Brazil do not think so bragging about a molecule present in the venom of jararacussu pit viper would prevent coronavirus’ ability to multiply. It means that scientists could whip up an anti-Covid drug-using snake venom.

“It seems to boil down to an enzyme found in rattlesnake venom,” according to Floyd Chilton, Professor & Director of the Precision Nutrition and Wellness initiative at the University of Arizona. He got blood samples from about 130 patients in a New York ICU and discovered an enzyme found in the highest concentration of it that has ever been found in humans.

“This enzyme is a humanized version, part of the same family as the active ingredient in snake venom, so this enzyme has been around a hundred million years. In simple terms, this enzyme related to snake venom found in humans is likely causing tremendous damage leading to multiple organ failure and death.”

“Could this explain why some people who are very healthy and have no known underlying health conditions die from COVID-19?” asked a reporter. “It could,” Chilton answered. Though he did not finger the source of the venom as remdesivir, it seems like the most likely candidate.

U.S. public health anointed remdesivir the standard-of-practice for patients severely ill with stage-two inflammatory COVID in the ICUs all over America. It is well-known that remdesivir can destroy kidney function in as little as five days. This supposed antiviral agent is being used after the high-viral-load stage-one phase of COVID is over. How many ICU patients have been killed by remdesivir?

“Dr. Paul Marik, one of the best ICU doctors in America, testifies about the dangers of remdesivir and the corruption in our medical system for prescribing it. Though it is deadly, doctors are being incentivized to use it on patients. Remdesivir killed more than 50% of the animals during its clinical trials. Yet the FDA still approved it.” The FDA is an abomination that should be canceled!

Remdesivir side effects

  • severe headache, pounding in your neck or ears;
  • fast, slow, or pounding heartbeats;
  • wheezing, trouble breathing;
  • swelling in your face;
  • nausea;
  • fever, chills, or shivering;
  • itching, sweating, or.
  • a light-headed feeling, like you, might pass out;
  • Multiple Organ Failure
  • Death

According to CMS (Centers for Medicare & Medicaid Services) data, almost 26% of people put on Remdesivir die. But it is a huge moneymaker for the government and Big Pharma.

The Palm Study Group investigated four drugs for the use of Ebola. The results were published on December 12, 2019, in the New England Journal of Medicine. That date is particularly important because that signaled the beginning of Covid. The Data Safety Monitoring Board of that study terminated the study of Remdesivir. TERMINATED, because Remdesivir INCREASED THE RISKS OF DEATH AND RENAL FAILURE. It was SUCH A TOXIC DRUG the Data Safety Monitoring Board terminated the use of REMDESIVIR.

Yet, in January and February of 2021, the NIH, in the ACTT 1 Study, enrolled patients in a study looking at Remdesivir for the treatment of Covid-19. The last patient was enrolled on April 19, 2020. Ten days later, before the study had actually terminated, Dr. Fauci sat in the Oval Office of the White House, and he said, “The trial was good news.”

Dr. Bryan Ardis Shouts Out

Dr. Bryan Ardis asks, “How is it possible that the United States of America, one of the top industrialized nations in the world, including in our healthcare systems, how is it possible that we still lead the world in COVID-19 deaths?”

“There’s only one thing we’ve done from the beginning that no one else was doing – and it was Anthony Fauci’s death protocol in hospitals using a drug called remdesivir that he knew would kill either a quarter to 30 percent of all people he gave the drug to in hospitals in five to 10 days.”

 

Dr. Ardis is kicking up an extraordinary amount of dust. Though communicated with warranted hysteria, he seems on target about remdesivir. Some grounding thoughts about the above video come from the Kennedy people, but the core story seems legitimate after putting all the information together.

Conclusion – Pharmaceutical Terrorism is Alive and Well

It is typical of the FDA to promote dangerous drugs like Remdesivir and get hysterical if someone uses a safe medical substance like chlorine dioxide. However, not only has chlorine dioxide shown to be effective for pennies against COVID, but it also is showing promise for the terrible damages the experimental genetic COVID genetic vaccines are doing to the public. Interestingly, Dr. Andreas Kalcker holds a patent for chlorine dioxide’s use as a universal snake antivenom.

Dr.Sircus is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

dr mark sircus qr code substack subscription image

Dr. Mark Sircus AC., OMD, DM (P)

Professor of Natural Oncology, Da Vinci Institute of Holistic Medicine
Doctor of Oriental and Pastoral Medicine
Founder of Natural Allopathic Medicine

Oncology Banner

Join 60,000 others
in my newsletter and
get 5 chapters for free!

Hydrogen Medicine eBook Cover

comments

For questions pertaining to your own personal health issues or for specific dosing of Dr. Sircus's protocol items please seek a consultation or visit our knowledge base to see if your question may have been answered previously.